Highlights and Quick Summary
- SG&A Expenses for the quarter ending December 31, 2022 was $10.3 Million (a 15.17% increase compared to previous quarter)
- Year-over-year quarterly SG&A Expenses decreased by -47.13%
- Annual SG&A Expenses for 2022 was $48 Million (a -7.67% decrease from previous year)
- Annual SG&A Expenses for 2021 was $52 Million (a -28.48% decrease from previous year)
- Annual SG&A Expenses for 2020 was $72.7 Million (a -26.3% decrease from previous year)
- Twelve month SG&A Expenses ending December 31, 2022 was $49 Million (a -11.58% decrease compared to previous quarter)
- Twelve month trailing SG&A Expenses decreased by -21.36% year-over-year
Trailing SG&A Expenses for the last four month:
31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
---|---|---|---|
$49 Million | $55.4 Million | $57.4 Million | $62.3 Million |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical SG&A Expenses of Precigen, Inc.
Most recent SG&A Expensesof PGEN including historical data for past 10 years.Interactive Chart of SG&A Expenses of Precigen, Inc.
Precigen, Inc. SG&A Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $10.35 | $8.99 | $10.06 | $19.58 | $48.01 |
2021 | $16.76 | $10.98 | $14.95 | $18.7 | $51.99 |
2020 | $11.03 | $22.31 | $17.87 | $21.49 | $72.69 |
2019 | $26.15 | $22.19 | $19.25 | $31.05 | $98.63 |
2018 | $12.29 | $38.71 | $34.43 | $39.74 | $125.16 |
2017 | $17.42 | $39.28 | $38.84 | $35.14 | $130.68 |
2016 | $35.36 | $33.81 | $30.26 | $42.88 | $142.32 |
2015 | $34.74 | $23.02 | $23.67 | $27.63 | $109.06 |
2014 | $19.78 | $14.85 | $15.38 | $13.64 | $63.65 |
2013 | $12.3 | $7.41 | $7.43 | $6.48 | $33.62 |
2012 | $5.05 | $6.33 | – | – | $24.9 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology